172 related articles for article (PubMed ID: 22931102)
1. Pharmacokinetics and pharmacodynamics of phase II drug metabolizing/antioxidant enzymes gene response by anticancer agent sulforaphane in rat lymphocytes.
Wang H; Khor TO; Yang Q; Huang Y; Wu TY; Saw CL; Lin W; Androulakis IP; Kong AN
Mol Pharm; 2012 Oct; 9(10):2819-27. PubMed ID: 22931102
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of dietary phytochemical indoles I3C and DIM: Induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates.
Saw CL; Cintrón M; Wu TY; Guo Y; Huang Y; Jeong WS; Kong AN
Biopharm Drug Dispos; 2011 Jul; 32(5):289-300. PubMed ID: 21656528
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and Pharmacodynamics of the Triterpenoid Ursolic Acid in Regulating the Antioxidant, Anti-inflammatory, and Epigenetic Gene Responses in Rat Leukocytes.
Zhang C; Wang C; Li W; Wu R; Guo Y; Cheng D; Yang Y; Androulakis IP; Kong AN
Mol Pharm; 2017 Nov; 14(11):3709-3717. PubMed ID: 29035547
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of 3,3'-diindolylmethane (DIM) in regulating gene expression of phase II drug metabolizing enzymes.
Wu TY; Huang Y; Zhang C; Su ZY; Boyanapalli S; Khor TO; Wang H; Lin H; Gounder M; Kagan L; Androulakis IP; Kong AN
J Pharmacokinet Pharmacodyn; 2015 Aug; 42(4):401-8. PubMed ID: 26138223
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of three oral formulations of curcumin in rats.
Wang L; Li W; Cheng D; Guo Y; Wu R; Yin R; Li S; Kuo HC; Hudlikar R; Yang H; Buckley B; Kong AN
J Pharmacokinet Pharmacodyn; 2020 Apr; 47(2):131-144. PubMed ID: 32020381
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane protects liver injury induced by intestinal ischemia reperfusion through Nrf2-ARE pathway.
Zhao HD; Zhang F; Shen G; Li YB; Li YH; Jing HR; Ma LF; Yao JH; Tian XF
World J Gastroenterol; 2010 Jun; 16(24):3002-10. PubMed ID: 20572303
[TBL] [Abstract][Full Text] [Related]
7. Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling.
Oh CJ; Kim JY; Min AK; Park KG; Harris RA; Kim HJ; Lee IK
Free Radic Biol Med; 2012 Feb; 52(3):671-682. PubMed ID: 22155056
[TBL] [Abstract][Full Text] [Related]
8. The role of Nrf2 signaling in the regulation of antioxidants and detoxifying enzymes after traumatic brain injury in rats and mice.
Hong Y; Yan W; Chen S; Sun CR; Zhang JM
Acta Pharmacol Sin; 2010 Nov; 31(11):1421-30. PubMed ID: 20953205
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane and phenylethyl isothiocyanate protect human skin against UVR-induced oxidative stress and apoptosis: role of Nrf2-dependent gene expression and antioxidant enzymes.
Kleszczyński K; Ernst IM; Wagner AE; Kruse N; Zillikens D; Rimbach G; Fischer TW
Pharmacol Res; 2013 Dec; 78():28-40. PubMed ID: 24121007
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane protects Microcystin-LR-induced toxicity through activation of the Nrf2-mediated defensive response.
Gan N; Mi L; Sun X; Dai G; Chung FL; Song L
Toxicol Appl Pharmacol; 2010 Sep; 247(2):129-37. PubMed ID: 20600217
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells.
Nair S; Barve A; Khor TO; Shen GX; Lin W; Chan JY; Cai L; Kong AN
Acta Pharmacol Sin; 2010 Sep; 31(9):1223-40. PubMed ID: 20729872
[TBL] [Abstract][Full Text] [Related]
12. [Effect of tBHQ and sulforaphane on Nrf2-ARE signaling pathway of Caco2 cells].
Wu XY; Qu LY; Quan K; Jiang YL; Tang XW
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 39(1):17-23. PubMed ID: 20175231
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice.
Hu R; Xu C; Shen G; Jain MR; Khor TO; Gopalkrishnan A; Lin W; Reddy B; Chan JY; Kong AN
Cancer Lett; 2006 Nov; 243(2):170-92. PubMed ID: 16516379
[TBL] [Abstract][Full Text] [Related]
14. Sulforaphane Ameliorates Okadaic Acid-Induced Memory Impairment in Rats by Activating the Nrf2/HO-1 Antioxidant Pathway.
Dwivedi S; Rajasekar N; Hanif K; Nath C; Shukla R
Mol Neurobiol; 2016 Oct; 53(8):5310-23. PubMed ID: 26433376
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism.
Jazwa A; Rojo AI; Innamorato NG; Hesse M; Fernández-Ruiz J; Cuadrado A
Antioxid Redox Signal; 2011 Jun; 14(12):2347-60. PubMed ID: 21254817
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane Protect Against Cadmium-Induced Oxidative Damage in mouse Leydigs Cells by Activating Nrf2/ARE Signaling Pathway.
Yang SH; Li P; Yu LH; Li L; Long M; Liu MD; He JB
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717178
[TBL] [Abstract][Full Text] [Related]
17. Identification of Nrf2-regulated genes induced by chemopreventive isothiocyanate PEITC by oligonucleotide microarray.
Hu R; Xu C; Shen G; Jain MR; Khor TO; Gopalkrishnan A; Lin W; Reddy B; Chan JY; Kong AN
Life Sci; 2006 Oct; 79(20):1944-55. PubMed ID: 16828809
[TBL] [Abstract][Full Text] [Related]
18. Requirement and epigenetics reprogramming of Nrf2 in suppression of tumor promoter TPA-induced mouse skin cell transformation by sulforaphane.
Su ZY; Zhang C; Lee JH; Shu L; Wu TY; Khor TO; Conney AH; Lu YP; Kong AN
Cancer Prev Res (Phila); 2014 Mar; 7(3):319-29. PubMed ID: 24441674
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Adaptive Neuroprotective Mechanisms of Sulforaphane and its Interconversion Product Erucin in in Vitro and in Vivo Models of Parkinson's Disease.
Morroni F; Sita G; Djemil A; D'Amico M; Pruccoli L; Cantelli-Forti G; Hrelia P; Tarozzi A
J Agric Food Chem; 2018 Jan; 66(4):856-865. PubMed ID: 29307179
[TBL] [Abstract][Full Text] [Related]
20. The aryl hydrocarbon receptor and estrogen receptor alpha differentially modulate nuclear factor erythroid-2-related factor 2 transactivation in MCF-7 breast cancer cells.
Lo R; Matthews J
Toxicol Appl Pharmacol; 2013 Jul; 270(2):139-48. PubMed ID: 23583297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
